[This corrects the article on p. 4512 in vol. 9, PMID: 29118913.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079144 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Author Correction: Forward genetic approach identifies a phylogenetically conserved serine residue critical for the catalytic activity of UBIQUITIN-SPECIFIC PROTEASE 12 in Arabidopsis.
Sci Rep
November 2024
Department of Genetics, Faculty of Sciences and Informatics, University of Szeged, Szeged, 6726, Hungary.
Author Correction: ABBV-744 as a potential inhibitor of SARS-CoV-2 main protease enzyme against COVID-19.
Sci Rep
October 2024
Department of Clinical Microbiology and Infectious Diseases, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 2193, South Africa.
Correction: Ubiquitin-specific proteases (USPs) in leukemia: a systematic review.
BMC Cancer
September 2024
Hematology, Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
Correction to: Effect of Renal Impairment on Pharmacokinetics and Safety of Ensitrelvir, a SARS‑CoV‑2 3CL Protease Inhibitor.
Infect Dis Ther
September 2024
Clinical Pharmacology and Pharmacokinetics, Shionogi & Co., Ltd., 3-13, Imabashi 3-Chome, Chuo-Ku, Osaka, 541-0042, Japan.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!